BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Oct 14, 2017

SEC Form 4/A — Form 4/A

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-05-27

Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-27	Common Stock	M	34078	$67.81	Acquired	109663	Direct
2015-05-27	Common Stock	S	34078	$130	Disposed	75585	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-27	Stock Option (Right to buy Common Stock)	$67.81	M	34078	Disposed	2023-05-14	Common Stock (34078)	Direct

Footnotes

F1: On May 28, 2015, the reporting person filed a Form 4 which inadvertently failed to report this option exercise.

F2: Trade made pursuant to a 10b5-1 plan executed on March 11, 2015.

F3: On May 28, 2015, the reporting person filed a Form 4 which inadvertently reported an incorrect transaction date and deemed execution date. This amendment corrects such date.

F4: All shares sold at same price.